This photo has been used for illustrative purpose only.
More than 30 studies are under way in France — of a world total of 860 — in search of drugs to treat the COVID-19 disease sweeping the world, infectologist Florence Ader said Sunday.
The research is "extremely active" in France involving some 1,600 patients, Ader told a news conference.|
Ader heads up a study dubbed Discovery in collaboration with several other European countries, with researchers conducting clinical trials of four potential treatments including the controversial hydroxychloroquine.
Of some 3,200 patients in Europe, at least 800 are in France. All are in hospital and severely ill with COVID-19.
Around the world some 150 projects seek to develop a vaccine against the novel coronavirus. France's prestigious Institut Pasteur will carry out trials on humans by this summer, Ader said.
The analyses suggest coronavirus patients are mostly experiencing the deadliest type of stroke.
Commonly used blood pressure medicines do not heighten susceptibility to COVID-19 infection, or increase the risk of becoming seriously ill with the disease.
About 100 research groups are pursuing vaccines with nearly a dozen in early stages of human trials or poised to start. It’s a crowded field, but researchers say that only increases the odds that a few might overcome the many obstacles that remain.
The Department said on its website it had “terminated” the Policymakers Educational China Trip Program, the US-China Friendship Program, the US-China Leadership Exchange Program, the US-China Transpacific Exchange Program
The United States has about 700 troops in Somalia focused on helping local forces defeat the al Qaeda-linked al Shabaab insurgency. The mission has received little attention in the United States, but has been considered a cornerstone
Authorities have apprehended, warned and penalised around 700,000 people since March for violating measures such as ignoring physical distancing and not wearing masks, police data shows.